Fingerprint
Dive into the research topics of 'Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care
Stephanie Behrens, Gail B. Rattinger, Sarah Schwartz, Joshua Matyi, Chelsea Sanders, M. Scott Deberard, Constantine G. Lyketsos, Joann T. Tschanz
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations